Analytes/procedures in
bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Additional Information
Participants will identify and characterize gains or losses and the cytogenetic location of any abnormalities detected.
This program is not appropriate for low resolution arrays that are designed to detect only aneuploidy.
Program Information
- Two 2.0‑μg DNA specimens
- For recommendations and requirements, see flow chart
Shipping Schedule
-
Shipment A: May 12
-
Shipment B: October 13
Help